LISATA THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 2891723, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2016-12-31) |
| Status | superseded |
| Entity | LISATA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:30:03.792427+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5a877e1c-511d-4099-a2e8-0750e4028882
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000320017-17-000008 · Open the official SEC filing →Retrieved: 2026-08-19T07:30:03.792427+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000320017/accounts-receivable/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5a877e1c-511d-4099-a2e8-0750e4028882
History
- no predecessors — first report